Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering blood: synthetic substitutes from fluorinated compounds.

Kenneth C Lowe1

  • 1Biotechnology Laboratory, School of Life and Environmental Sciences, University of Nottingham, University Park, Nottingham, UK. kclowe@nottingham.ac.uk

Tissue Engineering
|July 15, 2003
PubMed
Summary

Perfluorochemicals (PFCs) offer a safe, synthetic alternative to blood transfusions. Emulsified PFCs effectively deliver oxygen to tissues, maintaining oxygenation during blood loss without hemodynamic changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of the NO/cGMP pathway reduces the vasoconstriction induced by acellular and PEGylated haemoglobin.

Biochimica et biophysica acta·2008
Same author

The weak-acid preservative sorbic acid is decarboxylated and detoxified by a phenylacrylic acid decarboxylase, PadA1, in the spoilage mold Aspergillus niger.

Applied and environmental microbiology·2007
Same author

Perceptions in transfusion medicine: a pilot field study on risk and ethics for blood and blood substitutes.

Artificial cells, blood substitutes, and immobilization biotechnology·2007
Same author

Metabolite fingerprinting in transgenic lettuce.

Plant biotechnology journal·2006
Same author

Identification of the sites of deoxyhaemoglobin PEGylation.

The Biochemical journal·2006
Same author

Genomics and blood substitutes for 21st century Europe ("EuroBloodSubstitutes").

Artificial cells, blood substitutes, and immobilization biotechnology·2006

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Hematology

Background:

  • Conventional blood transfusions face safety and logistical challenges.
  • The search for effective blood substitutes is ongoing.
  • Perfluorochemicals (PFCs) are synthetic compounds with high oxygen-carrying capacity.

Purpose of the Study:

  • To evaluate perfluorochemical emulsions as a safe and effective alternative to blood transfusions.
  • To assess the efficacy of PFC emulsions in maintaining tissue oxygenation.
  • To explore the potential of PFCs in developing a totally synthetic blood substitute.

Main Methods:

  • Development of submicron emulsions of perfluorochemicals (PFCs).
  • Evaluation of emulsified PFCs as temporary, intravascular tissue-oxygenating fluids.

Related Experiment Videos

  • Clinical trials of a perflubron-based, phospholipid-stabilized emulsion.

    • Main Results:

    • Emulsified PFCs demonstrated safe injection into the bloodstream.
    • Perflubron-based emulsion adequately maintained tissue oxygenation during acute blood loss.
    • No abnormal hemodynamic changes were observed during clinical trials.

    Conclusions:

    • Perfluorochemical emulsions show promise as a short-term transfusion alternative.
    • These synthetic blood substitutes can maintain tissue oxygenation effectively.
    • Further development aims for a completely synthetic, bioengineered blood substitute.